SURPASS-CN-INS

A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes

TirzepatideCompletedCompletedPhase 3Open NCT05691712 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

SURPASS-CN-INS · Trial Tracker · ComplyRx